ClinicalTrials.gg
Status unknownNCT04935970Updated Jun 23, 2021

Metabolic Disorders and Vertigo

An observational study in Benign Paroxysmal Positional Vertigo (BPPV), Vestibular Migraine and Central Positional Vertigo, sponsored by I.M. Sechenov First Moscow State Medical University. Status unknown at 1 site in Russian Federation. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-06-23.

Sponsored by I.M. Sechenov First Moscow State Medical University · Observational

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
100
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D, homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and central origin (vestibular migraine). Also we will analyse another factors (such as anxiety and depression) and optimize therapeuthical approach accordingly with the data.

Read the detailed description

Dizziness causes up to 2 to 15% of primary neurological complaints. In some patients who have undergone acute vertigo, postural instability, persistent postural perceptual vertigo (PPPV) develops, while in other similar cases occurs full recovery. So, it is necessary to search for neurophysiological, metabolic and psychophysiological factors and associated premorbid conditions that affect the outcome of neurovestibular compensation.

The case-control study will include 2 groups of patients suffering from vertigo of central and peripherial etiology. First group is recruited with patients were diagnosed with peripherial vestibular disorders, such as benign paroxysmal positional vertigo (BPPV), Meniere disease, vestibular neuritis. The proposal number of subjects in the first group is about forty. The second group will consist of forty patients with central vestibular disfunction: vestibular migraine, central positional vertigo etc. The inclusion of patient with persistent postural perceptual dizziness is discussed. Patients will be tested for hydroxyvitamin D and homocysteine in serum using an enzyme-linked immunosorbent assay (ELISA). The perception of the severity of disability was assessed using the Dizziness scale Handicap Inventory (DHI). All patients will undergo psychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'sscale. Statistical analysis was carried out with the Statistical Analysis System (SAS) package. The relationships will be assessed using the chi squared test and logistic regression. The level of significance is set at p \< 0.05. The methods for small samples (Mann-Whitney U ) will be used. It is presumed that differences in vitamin D levels beetween two groups will be considerable.

02

Conditions studied

  • Benign Paroxysmal Positional Vertigo (BPPV)
  • Vestibular Migraine
  • Central Positional Vertigo
  • Vestibular Neuritis
  • Meniere Disease

Keywords

  • Benign paroxysmal positional vertigo (BPPV)
  • vestibular neuritis
  • vestibular migraine
  • central positional vertigo
  • Meniere disease
  • persistent postural-perceptual dizziness (PPPD)
  • vitamin D deficiency
  • hyperhomocysteinaemia
03

In context

Benign Paroxysmal Positional Vertigo

75 studies on the registry are indexed under Benign Paroxysmal Positional Vertigo; 15 are open to participants now.

This study's planned enrollment of 100 is close to the median of 104 across 11 observational studies indexed under Benign Paroxysmal Positional Vertigo.

Browse Benign Paroxysmal Positional Vertigo studies →

Lead sponsor

I.M. Sechenov First Moscow State Medical University is the lead sponsor of 137 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

patients from clinic with damage of peripheral and central origin

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written of participation in the study;
  • Age:over 18 years old
  • complaints of dizziness and insteadiness

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment (dementia)
  • Severe depression
  • Syncopal paroxysms
  • Epileptic seizures
  • Orthostatic hypotension
  • Severe arrhythmia, unstable angina pectoris, acute myocardial infarction
  • Pregnancy 8. Alcoholism, substance abuse and drug addiction
  • Organic liver and kidney diseases with the development of functional disorders.
  • Anemia ( \<10.5 g / dl for women and \<11.5 g / dl for men)
  • Active oncological process
  • Demyelinating and neurodegenerative diseases.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients with peripherial vestibular disorder

    Forty patients with BPPV, vestibular neuritis or another peripherial vestibular disorder

    Diagnostic Test: diagnostic blood test · Diagnostic Test: neuropsychological test

  • patients with central vestibular disorder

    Forty patients vestibular disorder of central origin

    Diagnostic Test: diagnostic blood test · Diagnostic Test: neuropsychological test

  • healthy controls

    twenty healthy control without balance problems

    Diagnostic Test: diagnostic blood test

Interventions

  • Diagnostic testdiagnostic blood test

    vitamin D deficiency/insufficiency reveal, hyperhomocysteinaemia reveal

  • Diagnostic testneuropsychological test

    neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.

06

What researchers measure

Primary outcomes

  1. vitamin D deficiency/insufficiency reveal

    enzyme-linked immunosorbent assay (ELISA).

    Time frame: Through 1-6 months of diagnosis established.

  2. hyperhomocysteinaemia reveal

    enzyme-linked immunosorbent assay (ELISA).

    Time frame: Through 1-6 months of diagnosis established.

Secondary outcomes

  1. correlation between metabolic and neuropsychological disorders

    neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Clinic of Neurology and Neurosurgery of I.M. Sechenov First Moscow State Medical University (Sechenov University)
    Moscow, Russian Federation
    Recruiting
    • Anna Bedenko, PhD student · Contact+79164989851
08

References and documents

Publications

  • Bedenko A.S., Antonenko L.М., Barinov A.N. Metabolic disorders in the pathogenesis of various causes of dizziness and instability // Annals of the Russian academy of medical sciences. - 2020. - Vol. 75. - N. 6. - P. 605-608. doi: 10.15690/vramn1244
  • Bedenko A.S. Vertigo in neurological practice: rare causes and difficult decisions. Medical alphabet. 2019;2(19):34-36. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-19(394)-34-36
  • Bedenko A.S. Metabolic factors in pathogenesis of migraine and unsteadiness. Medical alphabet. 2020;(33):18-20. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-18-20
  • Bedenko A.S. Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy. Epilepsy and paroxysmal conditions. 2020;12(3):177-181. (In Russ.)https://doi.org/10.17749/2077-8333/epi.par.con.2020.032

Individual participant data

Plan to share: No — I give my consent to provide actual study protocol. However, It is impossible to provide stastistical documents and primary patient's documentation (It is forbidden by Local Ethic Committee of Sechenov University)

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04935970
Responsible party
Sponsor
First posted
Jun 23, 2021
Start date
Dec 10, 2019
Primary completion
Dec 30, 2021 (estimated)
Completion
Aug 31, 2022 (estimated)
Last update
Jun 23, 2021

Study contacts

Ludmila Antonenko, professor
Contact
luda6917@yandex.ru
89265774431
Anna Bedenko, PhD student
Contact
mailanna91@yandex.ru
89164989851
Anna Bedenko, PhD student
principal investigator · I.M. Sechenov First Moscow State Medical University (Sechenov University)

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion